February 28, 2025 IPOPI regularly receives support from a broad range of companies involved in the manufacture of immunoglobulin therapies and the field of primary immunodeficiencies
January 10, 2023 Induction of miRNA targeting BTK in 13 AML individual examples upon 24h treatment with 10 nM panobinostat (PS)